Results 291 to 300 of about 129,945 (312)

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly  

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo, Michael Ong, David S P Tan   +2 more
exaly  

Rho-Kinase-Inhibitor bei ALS

InFo Neurologie + Psychiatrie
openaire   +1 more source

D2O als Inhibitor der anxin-induzierten RNS-Synthese

Die Naturwissenschaften, 1969
Helga Dahlhelm, G. H�bner
openaire   +1 more source

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann, Nadine Krüger, Tobias S Schiergens   +2 more
exaly  

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Nature Medicine, 2018
Yuting Sun, Jeffrey J Ackroyd, Stefan O Ciurea   +2 more
exaly  

Pharmacophore Model of ALS Inhibitors by DISCO Method

Acta Physico-Chimica Sinica, 2000
Miao Fang-Ming, Su Hua-Qing, Wang Jin-Ling, Li Ai-Xiu   +3 more
openaire   +1 more source

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

Nature Reviews Cancer, 2008
Ludger Hengst, Joyce M Slingerland
exaly  

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

Nature, 2009
Michael A Milhollen, James J Garnsey, Lawrence R Dick   +2 more
exaly